M3VMeVis Medical SolutionsM3V info
-info-24h
Global rank
Market cap$0
Change 7d-
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    MeVis Medical Solutions (M3V) Stock Overview

    MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological disorders. It offers X-ray modalities, including computed tomography, digital mammography, digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, its services are used for technical visualization and online training. The company was founded in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG operates as a subsidiary of Varex Imaging Deutschland AG.

    M3V Stock Information

    Symbol
    M3V
    Address
    Caroline-Herschel-Str. 1Bremen, 28359Germany
    Founded
    -
    Trading hours
    9:00 AM - 5:30 PM CET
    Website
    https://www.mevis.de
    Country
    🇩🇪 Germany
    Phone Number
    49 421 22495 0

    MeVis Medical Solutions (M3V) Price Chart

    -
    Value:-

    MeVis Medical Solutions Overview: Key Details and Summary

    Stock data
    2023
    Change
    Shares Outstanding
    1.82M
    0.00%
    Employees
    113.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org